thiotepa has been researched along with Corpus Luteum Cyst in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nerodo, GA | 1 |
| Nechaeva, ID | 1 |
| Kotova, DG | 1 |
| Livshits, MA | 1 |
| Rossoshanskiĭ, AA | 1 |
3 other studies available for thiotepa and Corpus Luteum Cyst
| Article | Year |
|---|---|
[Prognosis in cancer of the ovaries].
Topics: Adenocarcinoma; Cystadenoma; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fo | 1974 |
[Evaluation of the role of chemotherapy following radical surgery for cilioepithelial tumors of the ovaries].
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Chlorambucil; Cyclophosphamide; Female; Huma | 1972 |
[Lymphogranulomatosis of the mesenteric lymph nodes simulating inoperable cancer of the ovaries].
Topics: Adult; Diagnosis, Differential; Female; Hodgkin Disease; Humans; Mesentery; Ovarian Cysts; Ovarian N | 1967 |